14226-1-AP
antibody from Proteintech Group
Targeting: S100A9
60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14
Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14226-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14226-1-AP, RRID:AB_2254232
- Product name
- S100A9 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated S100A9 antibody (Cat. #14226-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references QDPR deficiency drives immune suppression in pancreatic cancer.
Hyperactivation of β-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis.
S100 calcium-binding protein A9 promotes skin regeneration through toll-like receptor 4 during tissue expansion.
Downregulation of S100A9 Reverses Cisplatin-Resistance and Inhibits Proliferation and Migration in Hypopharyngeal Carcinoma.
Single-cell RNA Sequencing Uncovered the Involvement of an Endothelial Subset in Neutrophil Recruitment in Chemically Induced Rat Pulmonary Inflammation.
TRPM8 deficiency attenuates liver fibrosis through S100A9-HNF4α signaling.
S100 calcium-binding protein A9 from tumor-associated macrophage enhances cancer stem cell-like properties of hepatocellular carcinoma.
KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer.
Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus.
Liu J, He X, Deng S, Zhao S, Zhang S, Chen Z, Xue C, Zeng L, Zhao H, Zhou Y, Bai R, Xu Z, Liu S, Zhou Q, Li M, Zhang J, Huang X, Chen R, Wang L, Lin D, Zheng J
Cell metabolism 2024 May 7;36(5):984-999.e8
Cell metabolism 2024 May 7;36(5):984-999.e8
Hyperactivation of β-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis.
Wang K, Wu J, Yang Z, Zheng B, Shen S, Wang RR, Zhang Y, Wang HY, Chen L, Qiu X
Cancer letters 2024 Apr 1;586:216690
Cancer letters 2024 Apr 1;586:216690
S100 calcium-binding protein A9 promotes skin regeneration through toll-like receptor 4 during tissue expansion.
Zhang Y, Song Y, Du J, Liu W, Dong C, Huang Z, Zhang Z, Yang L, Wang T, Xiong S, Dong L, Guo Y, Dang J, He Q, Yu Z, Ma X
Burns & trauma 2023;11:tkad030
Burns & trauma 2023;11:tkad030
Downregulation of S100A9 Reverses Cisplatin-Resistance and Inhibits Proliferation and Migration in Hypopharyngeal Carcinoma.
Zeng S, Tan G, Wang T, Wang X, Zhou Z, Xiao J, Li T, Zhang G, Li W
Journal of oncology 2022;2022:9341731
Journal of oncology 2022;2022:9341731
Single-cell RNA Sequencing Uncovered the Involvement of an Endothelial Subset in Neutrophil Recruitment in Chemically Induced Rat Pulmonary Inflammation.
Huang H, Yang Y, Song T, Yang Y, Zhu Y, Liu Z, Li L, Wang X
International journal of medical sciences 2022;19(4):669-680
International journal of medical sciences 2022;19(4):669-680
TRPM8 deficiency attenuates liver fibrosis through S100A9-HNF4α signaling.
Liu Q, Lei X, Cao Z, Zhang J, Yan L, Fu J, Tong Q, Qin W, Shao Y, Liu C, Liu Z, Wang Z, Chu Y, Xu G, Liu S, Wen X, Yamamoto H, Mori M, Liang XM, Xu X
Cell & bioscience 2022 May 7;12(1):58
Cell & bioscience 2022 May 7;12(1):58
S100 calcium-binding protein A9 from tumor-associated macrophage enhances cancer stem cell-like properties of hepatocellular carcinoma.
Wei R, Zhu WW, Yu GY, Wang X, Gao C, Zhou X, Lin ZF, Shao WQ, Wang SH, Lu M, Qin LX
International journal of cancer 2021 Mar 1;148(5):1233-1244
International journal of cancer 2021 Mar 1;148(5):1233-1244
KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer.
Liao W, Overman MJ, Boutin AT, Shang X, Zhao D, Dey P, Li J, Wang G, Lan Z, Li J, Tang M, Jiang S, Ma X, Chen P, Katkhuda R, Korphaisarn K, Chakravarti D, Chang A, Spring DJ, Chang Q, Zhang J, Maru DM, Maeda DY, Zebala JA, Kopetz S, Wang YA, DePinho RA
Cancer cell 2019 Apr 15;35(4):559-572.e7
Cancer cell 2019 Apr 15;35(4):559-572.e7
Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus.
Mosch J, Gleissner CA, Body S, Aikawa E
Histology and histopathology 2017 Mar;32(3):293-306
Histology and histopathology 2017 Mar;32(3):293-306
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human heart tissue were subjected to SDS PAGE followed by western blot with 14226-1-AP(S100A9 antibody) at dilution of 1:500
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human breast cancer using 14226-1-AP(S100A9 antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The S100A9 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human S100A9. This antibody recognizes human antigen. The S100A9 antibody has been validated for the following applications: ELISA, WB, IHC analysis.